637022-52-7

Basic information

• Product Name: 4-Bromo-1-chloro-2-(propan-2-yloxy)benzene
• Synonyms: 4-Bromo-1-chloro-2-(propan-2-yloxy)benzene
• CAS NO: 637022-52-7
• Molecular Formula: C₉H₁₀BrClO
• Molecular Weight: 249.5321
• Mol File: 637022-52-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-Bromo-1-chloro-2-(propan-2-yloxy)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-1-chloro-2-(propan-2-yloxy)benzene(637022-52-7)
• EPA Substance Registry System: 4-Bromo-1-chloro-2-(propan-2-yloxy)benzene(637022-52-7)

Safety Data

• Hazardous Substances Data: 637022-52-7(Hazardous Substances Data)

Upstream product

• 183802-98-4 5-bromo-2-chlorophenol 
• 1972-28-7 diethylazodicarboxylate 
• 67-63-0 isopropyl alcohol 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

1-ARYL-4-SUBSTITUTED PIPERAZINES DERIVATIVES FOR USE AS CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS

Compounds are provided that act as potent antagonists of the CCR1 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR1. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.